Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness

Clinical trial NCT03480698 · COMPLETED

Trial details

NCT number: NCT03480698
Sponsor: Ever Neuro Pharma GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Ischemic Stroke

Start date: 2018-04-24
Primary completion: 2024-04-30
Enrollment: 1851

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.